10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2011 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 29, 2012) | |||
(In Millions) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
Revenues: | |||
Product sales | $ 15,295 | 14,660 | 14,351 |
Other revenues | 287 | 393 | 291 |
Total revenues | 15,582 | 15,053 | 14,642 |
Operating expenses: | |||
Cost of sales (excludes amortization of certain acquired intangible assets presented separately) | 2,427 | 2,220 | 2,091 |
Research and development | 3,167 | 2,894 | 2,864 |
Selling, general and administrative | 4,486 | 3,983 | 3,820 |
Amortization of certain acquired intangible assets | 294 | 294 | 294 |
Other | 896 | 117 | 67 |
Total operating expenses | 11,270 | 9,508 | 9,136 |
Operating income | 4,312 | 5,545 | 5,506 |
Interest expense, net | 610 | 604 | 578 |
Interest and other income, net | 448 | 376 | 276 |
Income before income taxes | 4,150 | 5,317 | 5,204 |
Provision for income taxes | 467 | 690 | 599 |
Net income | 3,683 | 4,627 | 4,605 |
Earnings per share: | |||
Basic | 4.07 | 4.82 | 4.53 |
Diluted | 4.04 | 4.79 | 4.51 |
Shares used in the calculation of earnings per share: | |||
Basic | 905 | 960 | 1,016 |
Diluted | 912 | 965 | 1,021 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2011 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 29, 2012) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
Cash flows from operating activities: | |||
Net income | $ 3,683 | 4,627 | 4,605 |
Depreciation and amortization | 1,060 | 1,017 | 1,049 |
Stock-based compensation expense | 341 | 353 | 284 |
Deferred income taxes | (399) | (167) | 47 |
Property, plant and equipment impairments | 6 | 118 | 21 |
Dividend received from equity investee | 0 | 0 | 110 |
Other items, net | 63 | 140 | 111 |
Changes in operating assets and liabilities, net of acquisitions: | |||
Trade receivables, net | (557) | (210) | (36) |
Inventories | (383) | 153 | (134) |
Other assets | (133) | 36 | (3) |
Accounts payable | (95) | 142 | 71 |
Accrued income taxes | (20) | (656) | (142) |
Legal reserve | 780 | 0 | 0 |
Other liabilities | 773 | 234 | 353 |
Net cash provided by operating activities | 5,119 | 5,787 | 6,336 |
Cash flows from investing activities: | |||
Purchases of property, plant and equipment | (567) | (580) | (530) |
Cash paid for acquisitions, net of cash acquired | (701) | 0 | 0 |
Purchases of marketable securities | (21,183) | (14,602) | (12,418) |
Proceeds from sales of marketable securities | 20,871 | 10,485 | 8,252 |
Proceeds from maturities of marketable securities | 749 | 642 | 1,443 |
Other | 45 | (97) | 51 |
Net cash used in investing activities | (786) | (4,152) | (3,202) |
Cash flows from financing activities: | |||
Repurchases of common stock | (8,315) | (3,786) | (3,208) |
Repayment of debt | (2,500) | 0 | (1,000) |
Repayments of commercial paper | (762) | 0 | 0 |
Dividends paid | (500) | 0 | 0 |
Net proceeds from issuance of debt | 10,387 | 2,471 | 1,980 |
Net proceeds from issuance of commercial paper | 762 | 0 | 0 |
Other | 254 | 83 | 204 |
Net cash used in financing activities | (674) | (1,232) | (2,024) |
Increase in cash and cash equivalents | 3,659 | 403 | 1,110 |
Cash and cash equivalents at beginning of period | 3,287 | 2,884 | |
Cash and cash equivalents at end of period | 6,946 | 3,287 | 2,884 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2011 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2011 10-K (Filed: Feb 29, 2012) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2011 | Dec 31, 2010 | |
ASSETS | ||
Current assets: | ||
Cash and cash equivalents | $ 6,946 | 3,287 |
Marketable securities | 13,695 | 14,135 |
Trade receivables, net | 2,896 | 2,335 |
Inventories | 2,484 | 2,022 |
Other current assets | 1,572 | 1,350 |
Total current assets | 27,593 | 23,129 |
Property, plant and equipment, net | 5,420 | 5,522 |
Intangible assets, net | 2,584 | 2,230 |
Goodwill | 11,750 | 11,334 |
Other assets | 1,524 | 1,271 |
Total assets | 48,871 | 43,486 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||
Current liabilities: | ||
Accounts payable | 642 | 716 |
Accrued liabilities | 5,028 | 3,366 |
Current portion of long-term debt | 84 | 2,488 |
Total current liabilities | 5,754 | 6,570 |
Long-term debt | 21,344 | 10,874 |
Other noncurrent liabilities | 2,744 | 2,098 |
Contingencies and commitments | ||
Stockholders' equity: | ||
Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding - 795.6 shares in 2011 and 932.1 shares in 2010 | 27,777 | 27,299 |
Accumulated deficit | (8,919) | (3,508) |
Accumulated other comprehensive income | 171 | 153 |
Total stockholders' equity | 19,029 | 23,944 |
Total liabilities and stockholders' equity | 48,871 | 43,486 |
External Links | |
AMGEN INC (AMGN) Fiscal Year 2011 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |